Abstract:The title compound, [Co(4)(C(4)H(4)O(5))(4)(C(7)H(6)N(2))(8)]·20H(2)O, consists of tetra-nuclear Co(II) complexes and disordered uncoordinated water mol-ecules. The tetra-meric complex mol-ecule has symmetry. While two benzimidazole mol-ecules and a tridentate malate dianion coordinate a Co(II) ion, the carboxylate O atom from an adjacent malate dianion bridges the Co(II) ions to complete a distorted octa-hedral coordination geometry. The tridentate malate dianion chelates the Co(II) ion, and the chelate six- and five-membered rings show half-chair and envelope configurations, respectively. A face-to-face separation of 3.494 (9) Å between parallel benzimidazole ligands indicates the existence of π-π stacking between adjacent complexes. The crystal structure also involves N-H⋯O and O-H⋯O hydrogen bonds.

Decacarbonyl-1κ3C,2κ3C,3κ4C-μ-hydrido-1:2κ2H:H-(μ-quinoline-2-thiolato-1:2κ2S:S)diosmium(I)osmium(0)(3 Os—Os)

Decacarbonyl-1κ3C,2κ3C,3κ4C-μ-hydrido-1:2κ2H:H-(μ-quinoline-2-thiolato-1:2κ2S:S)diosmium(I)osmium(0)(3Os—Os)

Decacarbonyl-1κ3 C,2κ3 C,3κ4 C -μ- hydrido-1:22 H:H-(μ-quinoline-2- thiol-ato-1:2κ2 S:S)diosmium(I)osmium(0)(3 Os - Os)

cyclo-Tetra-μ-malato-κ16O,O′,O′′:O′′′-tetrakis[bis(1H-benzimidazole-κN3)cobalt(II)] eicosahydrate

Cyclo-Tetra-μ-malato-κ16o,o′,o′′:O′′′-tetrakis[bis(1h-benzimidazole-κn3)cobalt(ii)] Eicosahydrate

Diaquabis(4-hydroxybenzoato-κO)(1,10-phenanthroline-κ2N,N′)cobalt(II) Monohydrate

cyclo-Tetra-μ-malato-κO,O',O'':O'''-tetra-kis[bis-(1H-benzimidazole-κN)cobalt(II)] eicosa-hydrate.

Tris(1h-Benzimidazole-Kappa N-3)(Thiodiacetato-Kappa O-3,S,O ')cobalt(ii) Dihydrate

cyclo -Tetra-μ-malato-κ 16 O , O ′, O ′′: O ′′′-tetrakis[bis(1 H -benzimidazole-κ N 3 )cobalt(II)] eicosahydrate

Aqua(Oxydiacetato-Kappa O-3,O ',O '')(1,10-Phenanthroline-kappa N-2,N ')cobalt(ii) Sesquihydrate

Diaqua(5-nitro-1H-benzimidazole-κN3)(oxydiacetato-κO,O′,O′′)cobalt(II) Monohydrate

Hexakis(1h-Imidazole-Kappa N-3)Cobalt(Ii) Bis(3,5-Dinitrobenzoate) Dihydrate

8-Hydroxyquinolinium–dibromosuccinate–dibromosuccinic Acid (2/1/2)

(2,2′-Diamino-4,4′-bi-1,3-thiazole-κ<sup>2</sup><i>N</i><sup>3</sup>,<i>N</i><sup>3′</sup>)(oxydiacetato-κ<sup>3</sup><i>O</i>,<i>O</i>′,<i>O</i>′′)copper(II) monohydrate

Bis(1H-imidazole-&#954;N3)bis(2-oxidopyridinium-3-carboxylato-&#954;2O2,O3)cobalt(II)

Bis(2,2′-diamino-4,4′-bi-1,3-thiazole-N,N′)(dichloro)cobalt(II) Dihydrate

Diaquabis(1H-imidazole-κN<sup>3</sup>)bis(4-nitrobenzoato-κO)cobalt(II)

2-Methylsulfanyl-5,6-dihydro-2h-1,3-dithiolo[4,5-b][1,4] Dioxin-2-Ium Tetrafluoroborate

10-Hexyl-10h-phenothiazine-3-carbaldehyde

Diaquabis(1H-imidazole-κN3)bis(4-nitrobenzoato-κO)cobalt(II)

Tris(1H-benzimidazole-κN3)(oxydiacetato-κ3O,O′,O′′)cobalt(II)

Decacarbonyl-1&#954;3C,2&#954;3C,3&#954;4C-&#956;-hydrido-1:2&#954;2H:H-(&#956;-quinoline-2-thiolato-1:2&#954;2S:S)diosmium(I)osmium(0)(3 Os&#8212;Os)